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Abstract: Short-term energy deficit strategies are practiced by weight class and physique athletes,
often involving high protein intakes to maximize satiety and maintain lean mass despite a paucity
of research. This study compared the satiating effect of two protein diets on resistance-trained
individuals during short-term energy deficit. Following ethical approval, 16 participants (age:
28 ± 2 years; height: 1.72 ± 0.03 m; body-mass: 88.83 ± 5.54 kg; body-fat: 21.85 ± 1.82%) were
randomly assigned to 7-days moderate (PROMOD: 1.8 g·kg−1·d−1) or high protein (PROHIGH:
2.9 g·kg−1·d−1) matched calorie-deficit diets in a cross-over design. Daily satiety responses were
recorded throughout interventions. Pre-post diet, plasma ghrelin and peptide tyrosine tyrosine
(PYY), and satiety ratings were assessed in response to a protein-rich meal. Only perceived
satisfaction was significantly greater following PROHIGH (67.29 ± 4.28 v 58.96 ± 4.51 mm, p = 0.04).
Perceived cravings increased following PROMOD only (46.25 ± 4.96 to 57.60 ± 4.41 mm, p = 0.01).
Absolute ghrelin concentration significantly reduced post-meal following PROMOD (972.8 ± 130.4
to 613.6 ± 114.3 pg·mL−1; p = 0.003), remaining lower than PROHIGH at 2 h (−0.40 ± 0.06 v
−0.26 ± 0.06 pg·mL−1 normalized relative change; p = 0.015). Absolute PYY concentration increased
to a similar extent post-meal (PROMOD: 84.9 ± 8.9 to 147.1 ± 11.9 pg·mL−1, PROHIGH: 100.6 ± 9.5 to
143.3 ± 12.0 pg·mL−1; p < 0.001), but expressed as relative change difference was significantly greater
for PROMOD at 2 h (+0.39 ± 0.20 pg·mL−1 v −0.28 ± 0.12 pg·mL−1; p = 0.001). Perceived hunger,
fullness and satisfaction post-meal were comparable between diets (p > 0.05). However, desire to
eat remained significantly blunted for PROMOD (p = 0.048). PROHIGH does not confer additional
satiating benefits in resistance-trained individuals during short-term energy deficit. Ghrelin and
PYY responses to a test-meal support the contention that satiety was maintained following PROMOD,
although athletes experiencing negative symptoms (i.e., cravings) may benefit from protein-rich
meals as opposed to over-consumption of protein.
Keywords: dietary protein; satiety; ghrelin; peptide YY; resistance training
Nutrients 2019, 11, 56; doi:10.3390/nu11010056 www.mdpi.com/journal/nutrients
Nutrients 2019, 11, 56 2 of 21
1. Introduction
Weight loss is an essential component of success for many strength athletes, as well as individuals
involved in general strength training. Weight class athletes restrict dietary energy intake typically
for 7–21 days prior to a competition [1], or during phases of training, to enhance the strength to
body-mass ratio, improve body composition, and increase the competitive advantage in weight class
events [2]. For physique/ bodybuilding athletes, similar practices of caloric restriction often occurs
for longer time periods i.e., >12 weeks to reach a very low body fat percentage, often going below 5%
to improve aesthetical appearance and succeed in bodybuilding competitions [2,3]. During dieting
phases many athletes may substantially increase their protein intake, as this practice has been shown to
be beneficial to maintain lean mass whilst reducing body-fat [4–13]. Although the recommended daily
intake of protein for healthy adults has been indicated at 0.83 g·kg−1·d−1 ([14] with habitual protein
intakes being reportedly greater at ~1.2 g·kg−1·d−1 [15]), protein requirements for resistance-trained
individuals to achieve maximal fractional synthetic rate and strength performance may exceed these
recommendations ranging from 1.3 to 1.8 g·kg−1·d−1 [16,17]. During acute energy deficit, protein
requirements may be subtly higher at 1.8–2.0 g·kg−1·d−1 to offset lean muscle losses. There is, however,
controversy as to whether substantially higher protein intakes ranging from 2.3 to 3.1 g·kg−1·d−1 may
in fact yield optimal results [13] with evidence that resistance-trained athletes consume protein intakes
as high as 4.3 g·kg−1·d−1 [18].
Higher protein intakes may also provide an additional benefit of increased satiety. A recent
meta-analysis by Dhillon et al. (2016) concluded that higher protein meals (ranging from 97 to
188 g) increased fullness ratings more than lower protein meals [19]. However, this analysis focused
on short-term studies (up to 10 h) in untrained individuals and can therefore not necessarily be
extrapolated to longer-term satiety over several days/ weeks. There may be a possibility that a person
becomes accustomed to a high protein intake and that a further increase in protein intake does not
result in additional satiety. This point can be particularly important for strength athletes who generally
consume a higher protein diet beyond the recommended levels for maximal performance [16,17].
Very few long-term, randomized, controlled trials have examined satiety and ad libitum energy
intake in normal weighted individuals following a low-protein vs a high-protein diet [20–22].
Only three studies have been conducted on resistance-trained individuals showing that a higher protein
intake may be beneficial for muscle retention and well-being following a weight loss diet [4,6,23].
Walberg et al. have shown that even though a higher protein diet (1.6 g·kg−1·d−1) during an extreme
weight loss intervention (18 kcal·kg−1) led to positive nitrogen balance compared to a lower protein
group (0.8 g·kg−1·d−1); it also led to reduced maximal isometric muscular endurance in weight
lifters [6]. In a different study, 2.3 g·kg−1·d−1 protein intake was shown to be beneficial for muscle
retention in 40% energy deficit compared to the 1.0 g·kg−1·d−1 control group [4]. However, higher
protein intake was also associated with increased fatigue for participants in this study, although this
has been contested elsewhere [23].
The finding of increased fatigue is particularly important considering that many athletes increase
their protein intake during caloric restriction in order to limit muscle loss, reduce hunger and increase
the feeling of satiety [13]. An increase in fatigue can result in decreased motivation to train [4], reduced
training efficiency and thus have a negative effect on athletic performance [6] particularly during the
competition preparation phase, in which many weight-class strength athletes undergo weight loss
interventions. It is important to note that the control condition examined in this study [4] represented
an unusually low protein intake (1.0 g·kg−1·d−1) for strength athletes that is below the established
recommendations [16]. Equally so, very high protein intakes, exceeding these recommendations, may
not only negatively impact on an athletes’ well-being and reduce the effort given to training, but also
carries the risk of displacement of other nutrients.
Therefore, the aim of this study was to compare the satiating effect of two diets with a
different protein content in resistance-trained subjects in energy deficit, participant well-being and
training motivation. A moderately high protein diet (PROMOD) with an intake corresponding to
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the recommendation for maximal performance (1.8 g·kg−1·d−1) [16,17] and a very high protein
diet (PROHIGH) with a protein intake of 2.9 g·kg−1·d−1 were used as main interventions. It was
hypothesised that a protein intake of 2.9 g·kg−1·d−1 would not impact on satiety levels more so than
an intake of 1.8 g·kg−1·d−1 but may reduce the motivation to train.
2. Materials and Methods
2.1. Participants
This study was conducted in accordance with the Declaration of Helsinki, and the protocol was
approved by the Faculty of Science and Technology Ethics Committee, Anglia Ruskin University
(approval number: FST/FREP/15/595). A priori sample size based on G*power software (α = 0.05
and 1-β = 0.80) using satiety data from Mettler et al. (2010) [4] based on resistance training individuals
consuming 2.3 g·kg−1·d−1 vs. 1 g·kg−1·d−1, estimated 14 in each group. Participants were required to
have a resistance training background of >6 months, while actively training >3 h per week, in a similar
manner to previous research [4]. This was to ensure participants were undergoing habitual training
at the point of study inclusion, and beyond the time-frame typically employed during acute training
studies [24–29].
Informed consent was obtained from all individual participants prior to study inclusion.
All participants satisfactorily completed a health screen questionnaire, and had no known history of
cardiovascular or metabolic abnormalities (e.g., diabetes); or recent viral infections or injuries which
would prevent them from maintaining habitual training sessions. As part of the inclusion criteria,
participants were required to not have any blood related disorders, no known eating disorders and no
known adverse reactions to whey protein supplementation, gluten or coconut oil. Additionally, all
participants were required to not be taking any medication/supplementation which could influence
satiety levels. Lacto-vegetarians were eligible for the study.
Twenty-two individuals (13 men, 9 women) volunteered for study inclusion. However, five
participants withdrew prior to first dietary intervention (due to personal factors conflicting with
the study requirements) and one participant did not complete the final assessment, resulting in
16 resistance trained participants in this randomised, controlled trial (9 men, 7 women). None of the
participants reported using any anabolic drugs, and were required to refrain from taking additional
supplementation (e.g., creatine, beta-alanine) for 4 weeks prior to and during the study. Participant
characteristics are shown in Table 1.
Table 1. Participant characteristics and baseline measurements.
Variable All Participants (n = 16) Male (n = 9) Female (n = 7)
Age (years) 28 ± 2 26 ± 2 30 ± 3
Height (m) 1.72 ± 0.03 1.79 ± 0.02 1.63 ± 0.04 *
Body-mass (kg) 88.83 ± 5.54 95.68 ± 5.73 80.01 ± 6.21
Body-fat (%) 21.85 ± 1.82 18.33 ± 1.91 26.37 ± 2.57 *
BIA FM (kg) 25.52 ± 3.37 23.12 ± 3.02 28.60 ± 6.82
BIA FM (%) 27.53 ± 2.46 23.40 ± 1.99 32.84 ± 4.40 *
BIA FFM (kg) 63.31 ± 3.50 72.56 ± 3.05 51.41 ± 3.48 *
BIA FFM (%) 72.47 ± 2.46 76.60 ± 1.99 67.16 ± 4.40 *
PA (◦) 8.27 ± 0.16 8.71 ± 0.10 7.70 ± 0.19 *
TBW (%) 52.26 ± 1.77 55.23 ± 1.43 48.43 ± 3.17 *
ICW (%) 58.49 ± 0.81 59.48 ± 0.48 57.23 ± 1.43
ECW (%) 41.48 ± 0.81 40.52 ± 0.84 42.71 ± 1.45
Data presented as mean ± SE. Body-fat (%) refers to estimation via skinfold measures. BIA denotes bioelectrical
impedance analysis. FM = fat-mass; FFM = fat-free mass; PA = phase angle; TBW = total body water;
ICW = intracellular water; ECW = extracellular water. Hydration markers from BIA. * denotes significantly different
to male cohort, p ≤ 0.05.
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2.2. Pre-Intervention Measures
All testing took place within the Cambridge Centre for Sport and Exercise Science, Human
Physiology Laboratory, Anglia Ruskin University, Cambridge. Prior to main trial procedures,
participants were required to visit the laboratory ~72–96 h prior to start of the first and second trials to
ascertain body composition measures required for energy intake calculations. As such, participants
were requested to arrive acutely fasted (i.e., no food within 3 h of assessment, and maintain habitual
hydration patterns) with last consumption of fluid (~0.5 L water) 1 h prior to assessment to standardise
procedures. Body-mass (Seca 799, Hamburg, Germany), height (Seca CE123 stadiometer, Hamburg,
Germany) and body composition were assessed under temperature controlled conditions.
Following a standardized 5-min resting period in a supine position, single frequency bioelectrical
impedance (Impedimed DF50, Carlsbad, CA, USA) was undertaken for initial assessment of body
composition measures, with particular emphasis on hydration indices (to confirm adherence to the
pre-testing requirements) and phase angle (a proxy marker of muscle quality to confirm trained
status (with >7.0 reported for female athletes, and >8.0 for male athletes from previous research [30]).
In addition, estimated body fat was evaluated using an 8 site skinfold calliper assessment (using
guidelines outlined by the International Society for the Advancement of Kinanthropometry (ISAK)).
All body composition measures were undertaken by the same researcher. Within the same timeframe,
participants completed habitual food intake and training diaries.
2.3. Dietary Assessment
As part of pre-intervention measures, and throughout the intervention, participants were
requested to maintain habitual food/activity diaries (following individual guidance in diary collation,
with emphasis on meal content, portion size and weight, and fluid intake) using the smart phone
app/browser program (www.MyFitnessPal.com). This method has been shown to be a reliable food
tracking method used in previous studies [31–33]. Diaries were assessed using Nutritics Professional
Dietary Analysis software (Nutritics Ltd., Co. Dublin, Ireland). Initial assessment was used to
monitor typical food choices and habitual caloric balance (including criterion assessment of training
levels). From this, assessment of individual maintenance caloric intake was undertaken using the
formula of Katch-McArdle (1996) based on an estimated resting daily energy expenditure (RDEE)
of 370 + (21.6 * lean body weight in kg) and adjusted against training requirements and non-exercise
adaptive thermogenesis [34], based on previous research [35].
2.4. Experimental Design and Intervention Measures
This study employed an experimental, randomised controlled, counter-balanced, crossover design.
Participants were randomly assigned to a 7-day matched calorie-restricted diet (20% from estimated
maintenance calories) of either moderate (1.8 g·kg−1·d−1) or high (2.9 g·kg−1·d−1) total protein
intake (PROMOD and PROHIGH respectively) with a fixed frequency of 4 meals per day. Guidance on
meal intake, food options in line with habitual patterns and portion size was provided to each
participant, along with provision of additional whey protein to supplement daily intake where required.
Participants visited the laboratory prior to starting the dietary intervention (day 0), and again at on
the completion of the 7 days (day 8) for assessment of satiety measures to a test meal (see below).
After each diet, participants were required to undertake a 3-day period in which the same meal
frequency (4 meals per day) was maintained, and protein intake was fixed (1.8 g·kg−1·d−1). However,
energy, carbohydrate and fat intake was permitted ad libitum at each meal until participants felt full.
Perception of satiety was noted by participants across each day during this period. This was included
to determine the dieting condition less likely to result in acute post-diet overeating.
Throughout this 10-day period, participants recorded all food and fluid intakes using an
individually allocated MyFitnessPal account, and maintained habitual training patterns. Compliance of
dietary intake was checked daily by the research team, and further individual support was provided
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as required to meet expected intakes. At the end of the first dietary period, participants undertook a
washout period and returned to habitual intake patterns for 4 weeks before returning to carry out the
opposing dietary condition. Mean dietary intakes at baseline and for each intervention are shown in
Table 2.
Table 2. Mean dietary intake at baseline and across intervention periods.
Variable Category
PROMOD PROHIGH
PRE POST PRE POST
Energy Intake (kcal·d
−1) 2359.44 ± 220.84 * 2057.44± 104.47 2270.71 ± 150.41 * 2119.44 ± 122.79
(kcal·kg−1·d−1) 26.89 ± 1.94 23.83 ± 0.93 25.53 ± 1.17 24.35 ± 0.84
Protein Intake
(g·d−1) 158.19 ± 13.55 162.94 ± 10.14 166.71 ± 18.33 256.13 ± 16.64 a,b
(g·kg−1·d−1) 1.80 ± 0.12 1.84 ± 0.02 1.84 ± 0.15 2.89 ± 0.01 a,b
(%EI) 27.79 ± 1.98 31.68 ± 1.33 28.79 ± 2.13 48.44 ± 1.93 a,b
Carbohydrate
Intake
(g·d−1) 220.75 ± 25.34 238.75 ± 13.32 221.79 ± 12.07 160.88 ± 13.88 a,b
(g·kg−1·d−1) 2.57 ± 0.25 2.81 ± 0.18 2.55 ± 0.16 1.90 ± 0.16 a,b
(%EI) 38.08 ± 2.52 46.55 ± 1.32 a 40.28 ± 2.45 30.32 ± 1.82 a,b
Fat Intake
(g·d−1) 90.94 ± 11.40 46.88 ± 2.62 a 73.79 ± 7.68 47.31 ± 2.80 a
(g·kg−1·d−1) 1.02 ± 0.11 0.55 ± 0.03 a 0.83 ± 0.08 b 0.55 ± 0.03 a
(%EI) 14.83 ± 0.77 9.12 ± 0.25 a 12.86 ± 0.90 b 8.94 ± 0.21 a
Data presented as mean ± SE, and for macronutrient categories expressed in grams per day, grams per kg per
day, and percentage of energy intake (EI). PROMOD denotes moderate protein condition (target: 1.80 g·kg−1·d−1);
PROHIGH denotes high protein condition (target: 2.90 g·kg−1·d−1). * denotes main effect for time (p = 0.04), but
no significant post-hoc findings. a denotes significantly different to PRE within condition (p ≤ 0.005). b denotes
significantly different to PROMOD at same time-point (p ≤ 0.024).
2.5. Laboratory Measures
Laboratory assessment took place on day 0 and 8 of each main intervention period, in addition
to pre-trial body composition measures. Participants were instructed to refrain from strenuous
physical activity 24–48 h prior to all laboratory visits, arrive strictly overnight fasted (>12 h) and
avoid any undue exertion travelling to the laboratory. Upon arrival, participants were required to
rest in a seated position for ~30 min without any undue distractions and complete an online satiety
questionnaire (see below). Following this, a venous whole blood sample (T0) was collected from
participants by a qualified phlebotomist into duplicate 4 mL K3EDTA vacutainers (Greiner Bio-One
GmbH, Kremsmunster, Austria). Once collected, stabilisers were added to each of the samples prior
to being centrifuged for 15 min at 3000 g. The plasma layer was pipetted and aliquoted into sterile,
non-pyrogenic, polypropylene cryovials (Fisherbrand, Fisher Scientific, Loughborough, UK) and
immediately frozen at −20 ◦C for later assessment of satiety hormones: ghrelin and peptide YY (PYY).
Body composition measures (height, weight, bioelectrical impedance) were assessed at the end of each
7-day intervention period as previously described.
2.6. Test Meal and Satiety Measures
At each visit for both intervention conditions, following resting measures, participants consumed
a standardised high-protein breakfast meal (Asda Scottish porridge oats (Asda Stores Ltd., Leeds,
UK) comprising (per 100g): 367 kcal; 12.0 g protein; 61.0 g carbohydrate; 6.2 g fat), added whey
protein (Pure Protein GF-1, USN UK Ltd., Longbridge, Birmingham, UK), coconut oil (Asda 100% raw
extra virgin coconut oil, Asda Stores Ltd., Leeds, UK) with 200 mL water under supervision based
on individual estimated caloric requirements for the PROHIGH condition and a protein content of
0.725 g·kg−1). On immediate completion of the test meal, a stopwatch was started and participants
captured their subjective post-prandial satiety responses using a previously validated satiety/hunger
questionnaire based on a standard 100 mm visual analogue scale [36,37] at 15, 30, 60, 90 and 120 min.
The questionnaire was based on immediate response to set questions (“How ‘hungry’ do you feel?”;
“How ‘full’ do you feel?”; “How ‘satisfied’ do you feel?”; “How ‘much’ can you eat right now?”).
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Participants were required to remain in a quiet, seated position during this time with no activity except
light reading, and moving to a designated couch (supine position) for collection of blood samples
at T60 and T120 (minutes) for assessment of selected satiety hormones. Data was normalised to
individual relative change and relative change differences in a similar manner to blood analyses (see
Section 2.8 below).
2.7. Post-Laboratory Measures and Support
An online satiety questionnaire was additionally completed at the end of each day across the
7-day intervention, and during the post-diet 3-day ad libitum period. The questionnaire captured
individual perceived responses to the following questions: (i) how hungry were you today?, (ii) how
full were you today?, (iii) how satisfied were you today with your diet?, (iv) how much do you think
you can eat right now?, (v) how high have your food cravings been today?, (vi) how often did you feel
energetic and active today?, (vii) how often were you in a good mood today?, (viii) how much did you
enjoy your training today?, (ix) how much do you feel you can give your best effort at training today?.
Mean data was collated for days 1–3 and 5–7 across the intervention period, and for days 1–3 of the
ad libitum period. To increase dietary compliance during each intervention period, participants were
provided with additional whey protein (Pure Protein GF-1, whey protein concentrate/ soya protein
isolate, USN UK Ltd., Longbridge, Birmingham, UK) comprising (per 100g): 370 kcal; 71 g protein;
9.8 g carbohydrate; 4.4 g fat.
2.8. Biochemical Analyses
All samples were analysed at the Department of Surgery, Addenbrookes Hospital, Cambridge.
Plasma samples with 4-(2-Aminoethyl) benzenesulfonyl fluoride hydrochloride (AEBSF; Sigma, Dorset,
UK) to a final concentration of 1 mg·mL−1 were frozen to−20 ◦C within 30 min of centrifuging (15 min
at 3000 g). Samples were subsequently thawed aseptically in a 37 ◦C water bath, centrifuged at 3000 g
for 5 min to sediment any cryoprecipitates and then analysed in duplicate using a human total ghrelin
ELISA kit or human PYY ELISA kit (EMD Millipore Corporation, Billerica, MA, USA) for ghrelin and
PYY measurements according to manufacturers’ instructions. ELISA plates were read using a FLUOstar
OPTIMA plate reader (BMG Labtech, Aylesbury, UK). In addition to raw concentrations (pg·mL−1),
data were individually normalised as relative change (to reflect normalised post-intervention effects)
and relative change differences (to reflect normalised intervention effects taking into consideration
pre-intervention results) according to the following equations:
Relative change (relative ∆ pg·mL−1) = x−yx where x = pre-meal resting sample, y = post-meal
respective sample time-points (i.e., 60, 120 min);
Relative change difference (relative ∆ difference pg·mL−1) =
( xpost−ypost
xpost
)
−
( xpre−ypre
xpre
)
where
pre = pre-intervention results, post = post-intervention results.
2.9. Statistical Analyses
Statistical analyses were performed using SPSS (v24, IBM, Armonk, NY, USA). Dependent variable
distributions were assessed for normality using a Shapiro-Wilk test as well as manual inspections of
M-estimators, histograms, stem-and-leaf plots and boxplots. Potential order and treatment effects
were assessed prior to main analyses using a paired samples t-test. Baseline participant characteristics
(gender) were assessed using an independent samples t-test. A mixed design repeated measures
ANOVA (diet, time) was performed for main analyses, with Bonferonni post-hoc comparisons where
applicable. Where pertinent, relative change questionnaire scores were assessed using a paired
samples t-test. An alpha level of ≤0.05 was employed for statistical significance. Data are reported as
mean ± S.E.
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3. Results
3.1. Nutrition Intake and Body Composition Data
Mean dietary intake across both interventions is shown in Table 2. Prior to starting
the first intervention average caloric intake for all participants was significantly greater
(2379.81 ± 201.48 kcal·d−1, F = 5.07, p = 0.013, ηp2 = 0.25) in comparison to main intervention
intakes, although similar to predicted habitual intakes when taking into consideration rest days
(2381.25 ± 131.31 kcal·d−1). Across intervention periods, targeted caloric deficit was achieved in
relation to estimated maintenance calories (based on individual requirements for both training and
rest days) for both PROMOD (−22.9 ± 1.0%) and PROHIGH (−21.0 ± 1.1%) conditions.
Whilst protein was generally maintained during PROMOD compared with pre-intervention intakes,
PROHIGH resulted in an expected increase in relative protein from 1.84 ± 0.15 to 2.89 ± 0.01g·kg−1·d−1
(F = 78.29(diet x time), p < 0.0001, ηp2 = 0.84). Post-intervention protein intakes were significantly
different between conditions (p < 0.0001), with mean intakes demonstrating excellent compliance with
target amounts. Relative carbohydrate intake was reduced during PROHIGH by 25.37 ± 6.16% from
2.55 ± 0.16 g·kg−1·d−1 to 1.90 ± 0.16g·kg−1·d−1 (F = 11.54(diet x time), p = 0.004, ηp2 = 0.44), and was
significantly lower than PROMOD-post (p < 0.0001). To meet caloric deficit requirements, during both
interventions total fat intake was significantly reduced by 39.42 ± 5.76% (p < 0.0001) and 27.63 ± 6.35%
(p < 0.0001) for PROMOD and PROHIGH respectively (F = 4.64(diet x time), p = 0.048, ηp2 = 0.24). Following
interventions, no differences for fat intake were reported between conditions (p > 0.05). However,
relative fat intakes pre-intervention were significantly higher for PROMOD compared to PROHIGH
(p = 0.008).
Mean body-mass significantly decreased within both interventions (F = 24.00(time), p < 0.0001,
ηp2 = 0.62) by 1.28 ± 0.30% with PROMOD (from 88.37 ± 5.42 to 87.18 ± 5.31 kg, p = 0.001) and
by 1.49 ± 0.36% with PROHIGH (from 88.48 ± 5.54 to 87.14 ± 5.42 kg, p = 0.002) demonstrating
compliance with acute energy deficit based on estimated maintenance calories. This corresponded
with a significant within-condition reduction in phase angle (F = 26.02(time), p < 0.0001, ηp2 = 0.63) for
both PROMOD (−0.41 ± 0.09◦, p < 0.0001) and PROHIGH (−0.29 ± 0.12◦, p = 0.04). Short-term energy
deficit resulted in a reduction in hydration indices, with both total body water (PROMOD: 53.14 ± 1.81
to 51.16 ± 1.59%, p = 0.002; PROHIGH: 53.04 ± 1.70 to 51.24 ± 1.80%, p = 0.018) and intracellular water
(PROMOD: 59.07 ± 0.75 to 57.88 ± 0.67%, p = 0.001; PROHIGH: 58.89 ± 0.71 to 57.88 ± 0.81%, p = 0.035)
decreasing within-condition. It was noted that mean training frequency was comparable between
dietary conditions (PROMOD: 6.38 ± 0.63 sessions; PROHIGH: 7.00 ± 0.50 sessions, p = 0.44) across the
10-day intervention period.
3.2. Dietary Intervention Perceived Satiety Responses
Across both dietary interventions, participants maintained a daily satiety questionnaire as
previously described. Data, based on absolute values (using a 100 mm visual analogue scale), were
averaged for the beginning (days 1–3) and end of each intervention (days 5–7). Mean responses
are shown in Table 3. Perception of satisfaction was significantly greater at the end of PROHIGH
(F = 4.52(diet), p = 0.05, ηp2 = 0.23) compared with PROMOD over days 5–7 (67.29 ± 4.28 mm v
58.96 ± 4.51 mm respectively, p = 0.04). Participants also reported a significant mean increase in
perception of cravings (F = 5.93(time), p = 0.028, ηp2 = 0.28) within PROMOD only from days 1–3
(46.25 ± 4.96 mm) to days 5–7 (57.60 ± 4.41 mm, p = 0.01). No other differences were reported between
conditions, including perceived training enjoyment and motivation to train.
Nutrients 2019, 11, 56 8 of 21
Table 3. Satiety and well-being questionnaire responses during dietary intervention phases.
Question PROMOD1–3 PROMOD5–7 PROHIGH1–3 PROHIGH5–7
Hunger 48.54 ± 3.48 51.46 ± 4.89 43.33 ± 4.22 41.67 ± 3.68
Fullness 62.29 ± 4.11 58.65 ± 4.64 64.38 ± 3.81 65.52 ± 3.99
Satisfaction 65.42 ± 4.38 58.96 ± 4.51 68.65 ± 2.34 67.29 ± 4.28 a
Desire to eat 50.94 ± 5.53 57.92 ± 5.45 45.00 ± 5.13 46.15 ± 5.58
Cravings 46.25 ± 4.96 57.60 ± 4.41 b 40.83 ± 4.59 47.19 ± 4.60
Energy 65.00 ± 2.81 67.81 ± 4.54 64.48 ± 3.18 69.06 ± 4.64
Mood 72.92 ± 3.35 67.92 ± 5.33 67.71 ± 3.26 71.88 ± 3.89
Training enjoyment 72.29 ± 4.35 68.23 ± 4.73 71.67 ± 4.48 73.02 ± 4.19
Training motivation 71.67 ± 4.97 66.56 ± 4.68 70.21 ± 3.93 70.83 ± 5.92
Data represent mean scores over days 1–3 and days 5–7 during moderate (PROMOD) or high (PROHIGH) diet periods.
Data based on arbitrary units (a.u.) from participant responses using a visual analogue scale (VAS, 0–100 mm) and
presented as mean ± SE. Question categories paraphrased. a denotes significant difference to PROMOD5–7 (p = 0.04).
b denotes significant increase within group compared to days 1–3 (p = 0.01).
3.3. Test-Meal Satiety Hormone Responses
Absolute values: Mean plasma ghrelin and PYY concentrations in response to the test-meal are
shown in Table 4. No differences were reported for pre- or post-intervention concentrations between
conditions (p > 0.05) for either analyte prior to consuming the test-meal. However, both ghrelin and PYY
were notably lower (albeit non-significant, p = 0.06 and p = 0.11 respectively) at T0 following PROMOD
compared with pre-intervention data. Plasma ghrelin reduced as expected by T60 in all assessments,
but typically increased by T120 (F = 28.77(time), p < 0.001, ηp2 = 0.63), remaining significantly lower
than pre-meal concentrations (p ≤ 0.036). However, following PROMOD, plasma ghrelin continued
to decrease to 613.57 ± 114.26pg·mL−1 by T120 (p = 0.003 within condition compared to T0) and
was significantly different overall compared to pre intervention responses (p = 0.015). Across all
assessments, plasma PYY significantly increased from T0 to T120 (F = 33.05(time), p < 0.001, ηp2 = 0.70),
with no differences reported between pre- or post-intervention concentrations.
Table 4. Mean plasma ghrelin and peptide YY concentrations in response to test meal.
Hormone Time (mins)
PROMOD PROHIGH
PRE POST PRE POST
Ghrelin
(pg·mL−1)
0 1125.97 ± 125.85 972.81 ± 130.42 920.12 ± 143.43 1088.17 ± 158.77
60 696.42 ± 96.61 * 659.73 ± 86.39 * 672.27 ± 119.29 * 786.61 ± 117.33 *
120 758.91 ± 129.38 * 613.57 ± 114.26 *, a 714.75 ± 136.56 * 850.60 ± 147.68 *
PYY
(pg·mL−1)
0 103.62 ± 10.15 84.87 ± 8.94 87.94 ± 11.45 100.65 ± 9.54
60 130.83 ± 9.09 * 129.38 ± 10.49 * 133.84 ± 15.14 * 141.02 ± 12.23 *
120 137.60 ± 8.71 * 147.14 ± 11.94 * 142.11 ± 13.29 * 143.34 ± 11.98 *
Data presented as mean ± SE. PROMOD denotes moderate protein condition; PROHIGH denotes high protein
condition. Time-point 0 refers to resting concentrations pre-feeding; other time-points refer to corresponding time
post-breakfast meal. * denotes significant differences to 0 time-point within condition only (p ≤ 0.036). a denotes
overall difference to pre intervention responses (p = 0.015).
Relative values: Plasma ghrelin and PYY expressed as normalized relative change (individual
results and mean data, reflective of intervention diet effect) and normalized relative change difference
(mean data, reflective of overall change in comparison to habitual intake) are shown in Figures 1
and 2 respectively. Normalized relative change in ghrelin concentration was significantly lower
(F = 5.90(diet × time), p = 0.029, ηp2 = 0.30) at T120 following PROMOD (−0.40± 0.06 pg·mL−1) compared
to PROHIGH (−0.26 ± 0.06 pg·mL−1, p = 0.015), with no prior differences reported at T60 between
interventions (p > 0.05). Relative change difference in ghrelin concentration was comparable between
conditions (p > 0.05).
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Normalized relative change for PYY increased from 0.59 ± 0.14 pg·mL−1 at T60 to
0.79 ± 0.16 pg·mL−1 at T120 with PROMOD, but was not deemed significant (p=0.07, main effect
for time) in comparison to PROHIGH (0.46 ± 0.10 pg·mL−1 at T60 to 0.51 ± 0.12 pg·mL−1 at T120).
However, relative change difference for PYY was significantly greater for PROMOD at both T60
(0.26 ± 0.18 pg·mL−1) and T120 (0.39 ± 0.20 pg·mL−1) compared with negative findings for PROHIGH
at the same time-points (T60: −0.15 ± 0.11 pg·mL−1, T120: −0.28 ± 0.12 pg·mL−1; p ≤ 0.018).
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Figure 2. Plasma peptide YY concentrations following test-meal (pg·mL−1; mean ± SE): (A) individual
values expressed as normalised relative change to baseline levels; (B) mean values expressed as
normalised relative change to baseline levels; (C) mean relative difference change (taking into
consideration pre-intervention results). PROMOD and PROHIGH denote moderate and high protein
conditions. Dashed line provides reference point to pre-meal normalisation. * denotes significant
difference between dietary conditions at each time-point (p ≤ 0.018).
3.4. Test-Meal Satiety Questionnaire Responses
Satiety questionnaire responses to the test-meal following each intervention (normalized relative
change) are shown in Figure 3. Perception of hunger as significantly reduced (F = 15.34(time),
p < 0.0001, ηp2= 0.51) for 60 min post test-meal following both interventions (p ≤ 0.024) with no
differences reported between diets (p > 0.05). In a similar pattern, perception of fullness significantly
increased post-meal (F = 16.52(time), p < 0.0001, ηp2 = 0.52) and remained above pre-meal values at T120
for both interventions (p ≤ 0.05), with no differences reported between diets (p > 0.05). Interestingly,
following immediate completion of the test-meal satisfaction was only significantly increased with
PROMOD (p = 0.006), beyond which perception of satisfaction remained elevated across all time-points
within each dietary condition (F = 13.65(time), p < 0.0001, ηp2 = 0.48). Perception of desire to eat reduced
following consumption of the test meal as expected (F = 16.90(time), p < 0.0001, ηp2 = 0.53) and remained
lower than pre-meal values for 60 in in both interventions (p ≤ 0.02). However, perception of desire
to eat only remained blunted at T90 and T120 within-PROMOD only (p ≤ 0.048).
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conditions (mean ± SE). (A) Perception of hunger; (B) Perception of fullness; C) Perception of
satisfaction; (D) Perception of desire eat. Responses in relation to pre-meal (−30 min) time-point.
0 min denotes immediate completion of test meal. Dashed line pr vid s r ference poin to pre-meal
perceived state. * deno s significant di ference comp red to pr -meal time-point (p ≤ 0.05) within both
dietary condi ions. a denotes significant differ nce compared to pre-meal time-point for PROMOD only
(p ≤ 0.048). No differences reported be ween dietary conditions.
Satiety questionnaire responses to the test-meal expressed as normalized relative change difference
(taking into consideration pre-interv ntion responses) are shown in Figure 4. No significant differences
wer report within or between dietary conditions for perc ption of hunger, fullness or satisfaction
(p > 0.05). For perception of d sire to eat, a significant main effect for time was reported (F = 5.43(time),
p < 0.0001, ηp2 = 0.27), with post-hoc analysis demonstrating significant increas on im ediate
compl tion of the test-meal for PROHIGH only (p = 0.028).
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3.5. Ad libitum Intake and Satiety Responses
Mean dietary intake during the ad libitum phase following each dietary intervention is shown in
Table 5. Despite higher absolute energy and fat intakes with PROHIGH, no significant differences were
reported between conditions for any variable (p > 0.05). Compliance with target protein intake was met
for both conditions. Satiety responses across days 1-3 of the ad libitum phase are shown in Table 6, along
with delta scores in comparison to days 5-7 of the previous intervention. Perception of hunger was
significantly reduced following transition to the ad libitum period (F = 5.18(time), p = 0.038, ηp2 = 0.26)
within PROMOD only (−9.67 ± 4.68 mm, p = 0.046). Likewise, perception of fullness (F = 10.33(time),
p = 0.006, ηp2 = 0.41) and satisfaction (F = 5.72(time), p = 0.03, ηp2 = 0.28) were significantly improved
within-condition relative to the end of the PROMOD diet (fullness: 9.78± 3.74 mm, p = 0.015; satisfaction:
13.11 ± 4.33 mm, p = 0.005). Perceived desire to eat also reduced on transition to an ad libitum phase
(F = 14.86(time), p = 0.002, ηp2 = 0.50) for PROMOD only (−16.78 ± 4.54 mm, p = 0.001).
A significant interaction effect was reported for perceived cravings (F = 5.00(dietxtime), p = 0.041,
ηp2 = 0.25), with post-hoc analysis indicating a significant reduction for PROMOD (−13.00 ± 4.27 mm,
p = 0.004). The relative change in perceived cravings for PROMOD was significantly reduced in
comparison to PROHIGH (p = 0.04) following transition to an ad libitum phase. Participants reported
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improvements in general mood within-condition (p = 0.05) only. Perceived motivation to train was
reportedly improved with PROMOD (F = 4.52(time), p = 0.05, ηp2 = 0.23) by 8.97 ± 5.08mm (p = 0.05).
No other differences were reported between dietary conditions during the ad libitum phase (p > 0.05).
Table 5. Mean dietary intake during ad libitum period.
Variable Category PROMOD PROHIGH
Energy Intake (kcal·d
−1) 2197.81 ± 177.58 2348.14 ± 232.46
(kcal·kg−1·d−1) 25.64 ± 1.62 26.52 ± 1.81
Protein Intake
(g·d−1) 162.38 ± 11.18 165.07 ± 12.89
(g·kg−1·d−1) 1.85 ± 0.03 1.86 ± 0.07
(%EI) 30.87 ± 2.13 29.40 ± 1.89
Carbohydrate Intake
(g·d−1) 214.94 ± 19.61 230.61 ± 24.33
(g·kg−1·d−1) 2.57 ± 0.24 2.65 ± 0.23
(%EI) 39.14 ± 1.98 39.66 ± 1.85
Fat Intake
(g·d−1) 72.69 ± 9.71 81.29 ± 11.01
(g·kg−1·d−1) 0.84 ± 0.09 0.90 ± 0.09
(%EI) 12.64 ± 0.76 13.29 ± 0.70
Data presented as mean ± SE, and for macronutrient categories expressed in grams per day, grams per kg per
day, and percentage of energy intake (EI). PROMOD denotes post moderate protein condition; PROHIGH denotes
post high protein condition. During ad libitum phase, meal frequency set to 4 meals, and target protein intake of
1.80 g·kg−1·d−1, otherwise unrestricted. No significant differences reported between conditions.
Table 6. Questionnaire responses during ad libitum dietary phase.
Question Category PROMOD PROHIGH ∆PROMOD ∆PROHIGH
Hunger 41.67 ± 3.61 40.78 ± 3.48 −9.67 ± 4.68 a −0.89 ± 2.74
Fullness 69.00 ± 4.39 73.39 ± 3.10 9.78 ± 3.74 a 7.87 ± 4.61
Satisfaction 73.11 ± 3.80 71.56 ± 3.00 13.11 ± 4.33 a 4.26 ± 4.89
Desire to eat 39.67 ± 2.96 38.03 ± 3.62 −16.78 ± 4.54 a −8.12 ± 5.22
Cravings 42.89 ± 4.12 46.15 ± 4.23 −13.00 ± 4.27 a −1.04 ± 5.08 *
Energy 71.33 ± 3.31 71.93 ± 2.91 2.99 ± 4.30 2.87 ± 3.34
Mood 76.11 ± 4.03 77.55 ± 2.09 8.33 ± 3.70 a 5.68 ± 2.72 a
Training enjoyment 79.35 ± 4.44 74.67 ± 4.51 9.23 ± 6.57 1.67 ± 4.43
Training motivation 78.85 ± 5.39 72.89 ± 4.99 8.97 ± 5.08 a 1.33 ± 3.93
Data represent mean scores over days 1–3 during ad libitum post diet period. Data based on arbitrary units (a.u.)
from participant responses using a visual analogue scale (VAS) and presented as mean ± SE. ∆ scores are relative to
end of intervention diet. Question categories paraphrased. a denotes significant difference within group compared
to end of intervention diet (p ≤ 0.05).* denotes significant difference to ∆PROMOD (p = 0.04).
4. Discussion
The main finding from this study was that the perceived satiating effect of two diets with different
protein content was generally comparable in resistance-trained participants undergoing a period of
acute energy deficit. Therefore, consuming more protein during acute energy deficit does not appear
to improve perceived satiety, as reported elsewhere [38–42]. However, when considering hormonal
adaptations to an acute dietary intervention in response to a protein-rich test-meal, a moderate protein,
energy deficit diet (1.8 g·kg−1·d−1) was deemed more satiating when compared to a high protein
(2.9 g·kg−1·d−1) diet. These results suggest that whilst in acute energy deficit, a PROMOD diet may be
sufficient to maintain training requirements in accordance with previous recommendations [5,43,44].
It is, however, important to note that a PROHIGH diet did not appear to disadvantage participants and
may offer individual benefits discussed below.
Across the 7-day intervention period, participant responses to the daily satiety questionnaire
were largely similar for all categories, with the exception of both cravings and satisfaction (Table 3).
By the end of the dietary intervention, whilst consuming a PROMOD diet, participants reported
increased cravings, which was not experienced to the same extent following PROHIGH. Additionally,
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perceived satisfaction was not only maintained during PROHIGH, but was significantly greater than
PROMOD at the end of the intervention period. Similar findings in response to a high protein meal
have been observed elsewhere [45]. This implies that during short-term caloric deficit a substantial
increase in protein ratio beyond recommended levels for maximal lean muscle gain may be better
sustained by resistance trained athletes who are more prone to cravings. Participant well-being, mood,
training enjoyment and motivation to train were comparable between dietary conditions. As training
frequency was equally maintained across dietary conditions, this inferred that an increase in protein
intake beyond 1.8 g·kg−1·d−1 did not compromise training responses, and did not result in reduced
motivation or perceived energy during training as hypothesized.
In the current study subjects maintained their habitual training routine without any external
motivation that was intended to increase their performance. As exercise fatigue has been reported
to increase during acute caloric deficit [4], it is possible that participants in the current study
subconsciously decreased training effort, despite maintaining session frequency. Interestingly, phase
angle (PA) assessed via bioelectrical impedance indicated a significant reduction following both
dietary conditions, more notably with PROMOD. PA has been reported to be a proxy measure of
muscle “quality” and is associated with sex, age, body mass index (BMI) and fat mass percentage
(FM%) [30,46–48]. A decrease in PA during both dietary conditions may indicate unfavorable changes
to muscle integrity as a result of energy restriction. However, the comparable reduction in hydration
indices likely infers decreased PA was transient based on acute energy deficit. Our previous findings
demonstrated an increase in PA when resistance trainees underwent a period of supervised intensive
training to volitional exhaustion during short-term energy deficit when consuming a PROHIGH diet [30].
It is feasible, therefore, that in order to maintain muscle integrity during periods of acute caloric deficit
more intensive training intensity and substantially increased protein intake is required, which is
supported elsewhere [13].
Plasma ghrelin responses were comparable with previous research [45,49–52]. However, in
response to a laboratory test meal, notable differences were reported between dietary conditions.
Following PROMOD, plasma ghrelin remained significantly reduced at 2 h post-meal indicating a
sustained satiating effect. When data was considered as normalized relative change (Figure 1B), this
pattern was highlighted further with differences reported between dietary conditions in response to a
protein-rich test meal. Furthermore, as no differences were observed between dietary conditions when
taking into consideration pre-intervention ghrelin responses (Figure 1C), this would suggest that the
satiating effect following PROMOD was associated with the higher protein content of the test meal.
It should be noted that baseline protein intake for all participants was nearly identical to the
protein requirements for the PROMOD condition. Therefore, the sustained reduction in 2-h ghrelin
response observed following PROMOD may also be related to the energy balance of the individual
(both a reduction in caloric and fat intake) across the intervention period [53,54]. It is also noteworthy,
that following PROMOD, plasma ghrelin was reduced at T0 compared with pre-intervention levels
which presented an interesting trend (p = 0.06, ηp2 = 0.22) considering the reported increase in cravings
within-condition by day 7. As plasma ghrelin followed expected responses pre and post PROHIGH [55],
the findings indicate that satiety may be acutely enhanced by the consumption of a high-protein
meal during periods of energy deficit when following a PROMOD approach. Individuals experiencing
periodic cravings when following a PROMOD diet may therefore benefit by increasing the protein
content of individual meals when required [56] without necessarily over-consuming protein.
This may be important considering the potential risks of longer-term consumption of very
high protein intakes in some individuals (i.e., those with existing, or predisposition for, kidney
disease [57]), and current recognition that high protein diets modulate intestinal microbiota production
of tryptophan, leading to elevated metabolites (e.g., indoxyl sulphate) acting as uremic toxins [58,59].
There is also current suggestion that high protein diets may negatively impact intestinal function,
potentially via bacterial metabolites produced as a result of undigested proteins [60]. High protein
diets, in combination with reduced carbohydrate/fiber intake may reduce short-chain fatty acid
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concentrations, impacting on colonic environment/mucosa [15] which may influence individual health
in the longer term. This supports the contention that a PROMOD approach may be sufficient for
resistance-trained individuals during energy deficit.
On completion of the dietary interventions, absolute plasma PYY did not significantly differ
between conditions in response to a standardized test meal, as observed elsewhere [49]. The expected
increase in plasma PYY [52] in response to a protein-rich test meal was consistent, with a similar rate
of change from T0-T60, following both dietary conditions. It is, however, noteworthy that following
PROMOD, a greater rate of change in plasma PYY from T60-T120 was evident (p = 0.07), which
is comparable with the sustained satiating effect observed with plasma ghrelin. When data were
compared as normalized relative change (Figure 2B), no differences were reported between dietary
conditions (p = 0.06) potentially explained by the mixed individual responses observed. However, when
taking into consideration pre-intervention PYY responses (Figure 2C), an overall positive response
was observed for PROMOD at both T60 and T120 in contrast to PROHIGH. This infers that a PROMOD
intervention improved acute satiety to a greater extent than PROHIGH. Collectively, these results
suggest that individuals may become accustomed to a higher protein intake, and therefore chronic
consumption of a PROHIGH diet may lose its satiating effect over time [61].
Various factors modulate PYY concentrations, including acute/chronic energy balance, as well
as nutrient composition of a meal. High protein meal content has been shown to elicit greater PYY
secretion leading to short-term sensations of fullness [62,63]. PYY is an agonist at neuropeptide Y2
receptors and increasing levels leads to both reduced hunger perception and food intake [62,64].
In the current study, nutrient composition of the test-meals remained the same across all testing
sessions. Therefore, although absolute changes in PYY were not reportedly different between dietary
interventions, the relative change difference indicated that both the decrease in caloric intake, along
with the higher protein content of the test meal resulted in acute increases in PYY concentrations over
the 2-h monitoring period for PROMOD. Although not significant, the observed increase in absolute
PYY concentration for PROHIGH at T0 may be explained by the increase in dietary protein over the
7-days. However, the hormonal response to a protein-rich meal for PROHIGH was not considered
different to pre-intervention patterns. This further supports the contention that a moderate protein
diet favorably improved acute physiological satiety in contrast to very high protein intakes.
Perceived satiety responses to the protein-rich test meal were largely comparable between dietary
conditions in contrast to physiological responses. Only “desire to eat” remained significantly reduced
until 2 h post-meal with PROMOD (Figure 3D), which in part supported the satiating effect observed
for plasma ghrelin. However, this was not the case for perceived hunger, fullness or satisfaction.
Whilst perceived satisfaction was comparable between conditions beyond T15, it was noted that
participants reported being more satisfied on completion of the test-meal with PROMOD (T0, Figure 3C).
However, as the mean values at T0 were similar between conditions, it was noted that a trend towards
significance was observed for PROHIGH (p = 0.06) indicating that perceived responses to the test-meal
were likely comparable for satisfaction. Overall, our results support previous findings that circulating
levels of ghrelin and PYY do not correlate with the subjective perception of appetite [52,65].
Based on the acute energy deficit period undertaken it is feasible that perceived responses may not
have changed dramatically compared to habitual intake. Interestingly when test-meal questionnaire
responses were normalized in relation to pre-intervention results (Figure 4), no differences were
reported between dietary conditions. The only within-condition finding at T0 for “desire to eat” for
PROHIGH (Figure 4D), may be explained by the fact that the protein content of the test-meal was based
on the higher protein intervention. Therefore, following a 7-day high protein (2.9 g·kg−1·d−1) energy
deficit period, it is likely that participants had attained a degree of habituation to the protein intake and
hence experienced a greater “desire to eat” on completion of the test-meal. This is, in part, supported
by the hunger and fullness scores at T0, albeit non-significant.
On completion of the 7-day dietary intervention, participants then completed a 3-day period
in which protein intake was fixed at 1.8 g·kg−1·d−1, with ad libitum consumption of carbohydrate,
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fat and energy intake until perceived fullness. This was included to provide insight as whether
the preceding intervention increased the likelihood of over-eating on cessation of short-term energy
deficit. Although energy and fat intakes were reportedly greater following PROHIGH, no differences
were reported between groups during the ad libitum phase, as similarly observed elsewhere [64].
Despite having followed a monitored period of reduced (20%) energy intake, participants tended to
only partially increase caloric intake mainly through increased total fat closer to pre-intervention levels.
This suggests, at least in the short-term, that resistance-trained athletes are unlikely to over-consume
calories on completion of an energy deficit period. This may reflect the tendency to follow habitual
dietary intake patterns during periods of training.
In a similar manner, the satiety questionnaire responses during the ad libitum period were
comparable between dietary conditions. However, when relative responses were compared to the
end of the previous intervention period, the change from a PROMOD approach resulted in significant
within-condition improvements in hunger, fullness, satisfaction, desire to eat, as well as general
participants’ mood and motivation to train. Notably, the reduction in cravings observed following
PROMOD was significantly different to PROHIGH. Collectively this suggests that whilst a short-term
PROMOD energy deficit period may result in improved hormonal satiety responses, periodic inclusion
of higher protein intakes may support sustained periods in which athletes undergo caloric deficit.
Alternatively, athletes undergoing periods of energy deficit may physiologically benefit from a
PROMOD approach, but should be mindful of increasing protein content (either based on single
meals, or as a dietary approach) when perceived cravings or a reduction in mood and/or training
motivation occurs.
On completion of the study, several limitations were noted. Firstly, that in monitoring habitual
dietary intake a longer lead in period would have provided clearer insight. All participants
were resistance-trained individuals experienced in maintaining individual macronutrient ratios (i.e.,
1.8 g·kg−1·d−1) and followed regular training routines. Dietary records were kept in the days leading
into each testing period prior to each intervention. As such, the observed habitual intake (Table 2)
included the requested rest days and therefore did not reflect maintenance intakes expected when
taking into consideration training days over a typical week (i.e., 2628 ± 144 kcal·d−1). However, based
on the period collected, energy intakes were comparable to expected intakes for less active periods
(e.g., 2381 ± 131 kcal·d−1) for this cohort (comprising both male and female athletes). Therefore,
although the habitual intakes were comparable prior to each intervention phase, they likely do not
reflect accurate mean energy intakes. However, the decrease in body-mass observed across each
intervention, along with monitored reduced energy intakes, indicated that participants achieved the
20% energy deficit as expected.
Although training frequency was maintained across both intervention periods, training intensity
was not monitored. Therefore, although perceived energy, training motivation and training enjoyment
was not different between dietary conditions, it is difficult to know whether participants maintained
overall training intensity. It is feasible, as previously mentioned, that fatigue was offset through
a subconscious reduction in training intensity during the energy deficit period. Anecdotally, most
participants reported that the PROHIGH diet was challenging (i.e., reduced mental clarity) towards the
end of the intervention phase, possibly indicating that such diets may be poorly tolerated in the longer
term. Careful attention to monitoring training intensity, along with perceived well-being responses
during periods of acute energy deficit may be warranted to ensure performance maintenance.
Another limitation observed was that other gut hormones (i.e., glucagon-like peptide 1 (GLP-1)
and cholecystokinin (CCK)) were not assessed in this study. This would have supported our findings
in determining that a PROMOD diet had a greater acute satiating effect after consumption of a high
protein meal. GLP-1 for example is secreted in conjunction with PYY, and has been associated with
appetite response and decreased food intake [62,66–68]. An increased GLP-1 response to PROMOD
would provide clearer insight that the satiating effect of the test-meal was related to localized
stomach/intestinal responses to a protein-rich breakfast meal, and confirmed our reasoning that
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athletes may become accustomed to chronic consumption of a high protein diet. Likewise, adjunct
measurements of CCK released from the duodenum in response to meal consumption influences
satiety acutely [62]. Along with reduced ghrelin responses, measures of CCK would have supported
the contention that PROMOD resulted in greater satiety in this cohort.
Whilst the results from this study indicate that a PROMOD preferentially influences hormonal
responses to a test-meal, it is evident that perceived responses were comparable between intervention
diets. Further research is therefore warranted to assess whether perceived satiety responses are
different when undertaking prolonged energy deficit periods. This is pertinent considering previous
research has indicated that fasting ghrelin levels may be increased in response to longer term energy
deficit [69,70]. Furthermore, with current recognition that high protein diets (including type of dietary
protein) likely modulate gut microbiota, this may have inference to both neurotransmitter and satiety
responses (e.g., GLP-1), especially considering inter-individual variance [15].
Although the sample size in the current study was deemed sufficient based on a priori power
assessment (comparable to previous research [4]), determination of satiety responses in larger
resistance-trained cohorts is also warranted. In addition, with the observation that athletes may
benefit from consuming a PROMOD diet during energy deficit, but periodically include protein-high
meals to offset negative symptoms (i.e., cravings), assessment of nutritional periodization during
periods of caloric deficit would be beneficial to ascertain sustainability to such diets. Finally,
maintenance of training performance and lean gains during periods of acute or chronic energy
deficit should be considered to determine whether a PROMOD diet sustains beneficial responses
in resistance-trained athletes.
5. Conclusions
During acute energy deficit in resistance-trained individuals, consuming protein intakes in
excess of recommended athlete guidelines did not improve overall perceived satiety in comparison
to more habitual, moderate protein intakes. Furthermore, a PROMOD diet favorably improved
hormonal responses to a test-meal compared with a PROHIGH diet. Therefore, as long as training
motivation/ performance is not compromised during short-term energy deficit, moderate protein
intakes (1.8 g·kg−1·d−1) are likely to be adequate for resistance-trained individuals. The findings
also suggest that where individuals experience negative symptoms (i.e., cravings), implementation of
periodic high protein meals may be sufficient to maintain satisfaction, and diet sustainability.
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